3007907068-20190614

Syngene International Limited, Clinical Development Jun 2019 Inspection

1 Semicon Park, Phase Ii
Bangalore

The U.S. Food & Drug Administration (FDA) audited the Syngene International Limited, Clinical Development facility in Bangalore in Jun 2019. This inspection ended on 6/14/2019.

For full inspection history of this site (all known inspections with or without 483), we offer a SiteProfile Report.